Abstract Library

#1943 Neuroendocrine Tumors Committee of Reference Hospital: Evaluation of Health Care and Research Indicators

Introduction: Neuroendocrine tumors (NETs) require a multidisciplinary approach in expert centers which optimize results improving care and survival.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jimenez-Fonseca P, Vieitez J, Valdés N, Lauret M, Calvo-Temprano D,

Keywords: committee, indicator, multidisciplinary, resource,

#1133 Prognosis of Stage IV Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) According to the WHO Classification and the Primary Tumor Location

Introduction: WHO classification of GEP-NET is used to predict prognosis, yet survival within each grade shows wide variation. We hypothesized that primary tumor location may be partially responsible of this variability.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Carmona-Bayonas A

Authors: Carmona-Bayonas A, Jiménez-Fonseca P, Vieitez J, Menendez Prieto M, Soli M,

Keywords: GEP-NET, WHO classification, grade, survival,

#1116 Streptozotocin Based Chemotherapy in Advanced G2 Pancreatic Neuroendocrine Tumors (PNET): Efficacy According to KI67 Index

Introduction: Streptozotocin (STZ) with fluorouracil (FU) or doxorubicin (DOX) is approved in well differentiated advanced pancreatic neuroendocrine tumors (PNET).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Jimenez-Fonseca P

Authors: Jiménez-Fonseca P, Carmona-Bayonas A, Solís M, Vieitez J, Sanchez M,

Keywords: chemotherapy, streptozotocin, fluorouracil, PNET, Ki67,

#257 Doxorubicin, Etoposide and Cisplatin as first-line Treatment in Advanced Adrenocortical Carcinoma

Introduction: Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis in advanced setting due to its low chemosensibility. Mitotane and cisplatin-based regimens are the most frequently used treatments.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca F, Vieitez J, Crespo G, Frunza M, Izquierdo M,

Keywords: adrenocortical carcinoma, chemotherapy, cisplatin-regimen, Doxorrubicin, Etoposide, Mitotane,

#253 Description and Treatment of GEP NETs in a Spanish Hospital During 10 Years

Introduction: In our area the GEP NET incidence is similar to that of gastric and exocrine pancreatic cancers consequently being important to know their characteristics and the most convenient therapeutic approach.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vieitez J, Galvan J, Crespo G, Frunza M,

Keywords: gastroenteropancreatic neuroendocrine tumors, histology, chemotherapy, streptozocin-based regimen,